Loading...
XASXVLS
Market cap67mUSD
Jan 08, Last price  
1.93AUD
1D
1.58%
1Q
-15.72%
Jan 2017
48.46%
IPO
1,106.25%
Name

Vita Life Sciences Ltd

Chart & Performance

D1W1MN
XASX:VLS chart
P/E
11.84
P/S
1.45
EPS
0.16
Div Yield, %
3.13%
Shrs. gr., 5y
-0.08%
Rev. gr., 5y
12.50%
Revenues
74m
+10.88%
11,869,88414,376,27017,015,12820,190,56124,266,64630,191,00035,411,00036,580,00038,584,00037,858,00037,738,00041,151,00042,452,00046,481,00057,101,00066,886,00074,161,000
Net income
9m
+28.18%
-253,385353,477-328,1934,459,5191,212,5212,367,0004,748,0007,280,0004,391,0003,343,0002,863,0002,439,0003,136,0006,094,0008,292,0007,084,0009,080,000
CFO
13m
+68.97%
0567,416-2,390,377-838,6525,661,5801,383,0004,835,0006,115,0004,923,0004,710,0003,218,0002,842,0002,028,0007,544,0005,889,0007,683,00012,982,000
Dividend
Sep 20, 20240.035 AUD/sh
Earnings
Feb 24, 2025

Profile

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, and Thailand, Vietnam, Indonesia, and China. The company also offers various minerals, herbs, and superfoods. In addition, it provides products for therapeutic areas, such as nervous system; nutritional products and nutritional oils; immunity; hair, skin, and nails; liver and digestion; weight management; cardiovascular health; pain and inflammation; pregnancy and breastfeeding; men, women, and children's health; antioxidant; and bones and joints. The company markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Kirrawee, Australia.
URL
https://vitalifesciences.com/
IPO date
Aug 23, 2007
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
74,161
10.88%
66,886
17.14%
Cost of revenue
61,653
54,253
Unusual Expense (Income)
NOPBT
12,508
12,633
NOPBT Margin
16.87%
18.89%
Operating Taxes
3,373
3,397
Tax Rate
26.97%
26.89%
NOPAT
9,135
9,236
Net income
9,080
28.18%
7,084
-14.57%
Dividends
(3,367)
(3,038)
Dividend yield
Proceeds from repurchase of equity
663
271
BB yield
Debt
Debt current
60
300
Long-term debt
563
902
Deferred revenue
Other long-term liabilities
84
135
Net debt
(24,007)
(12,316)
Cash flow
Cash from operating activities
12,982
7,683
CAPEX
(660)
(139)
Cash from investing activities
(660)
(139)
Cash from financing activities
(2,875)
(3,105)
FCF
10,858
3,190
Balance
Cash
24,630
15,688
Long term investments
(2,170)
Excess cash
20,922
10,174
Stockholders' equity
43,331
36,503
Invested Capital
22,880
26,936
ROIC
36.67%
42.32%
ROCE
28.56%
34.04%
EV
Common stock shares outstanding
54,692
53,992
Price
Market cap
EV
EBITDA
13,020
13,232
EV/EBITDA
Interest
135
34
Interest/NOPBT
1.08%
0.27%